Health Canada regulates in vitro diagnostic devices (IVDs) under the Medical Devices Regulations. It uses a risk-based classification system (Class I–IV) to determine the applicable regulatory pathways. Class II–IV IVDs require a Medical Device Licence (MDL). On the...
A new sterilisation labelling rule has been introduced under the Medical Devices (Second Amendment) Rules, 2026. Effective from February 2027, the rule requires manufacturers outsourcing sterilisation to print the licence number of the sterilisation facility on...
FDA communication for medical devices is the structured process through which manufacturers interact with the U.S. FDA. The aim is to ensure compliance, safety, and timely approval of the products. It includes pre-submission meetings to clarify requirements, formal...
Selling medical devices in Europe is strategically valuable because the EU market is one of the largest and most regulated healthcare markets in the world. Achieving CE marking under the EU MDR or IVDR not only allows entry into Europe but also signals global...
Health Canada requires medical device manufacturers to conduct ongoing post-market surveillance. Mandatory summary reports, issue-related analyses, incident reporting, and foreign risk notifications are necessary requirements. Notably, these obligations apply...
MDEL annual license review (ALR) is a yearly renewal process for companies manufacturing, importing, or distributing medical devices in Canada. Health Canada oversees the ALR process. This review process ensures that MDEL holders remain consistently compliant with the...